Vincerx Pharma Inc (VINC)
0.6944
-0.03
(-3.56%)
USD |
NASDAQ |
May 17, 16:00
0.6944
0.00 (0.00%)
After-Hours: 20:00
Vincerx Pharma Total Liabilities (Quarterly): 11.70M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.70M |
| December 31, 2023 | 6.995M |
| September 30, 2023 | 10.54M |
| June 30, 2023 | 11.14M |
| March 31, 2023 | 12.98M |
| December 31, 2022 | 11.62M |
| September 30, 2022 | 12.67M |
| Date | Value |
|---|---|
| June 30, 2022 | 13.38M |
| March 31, 2022 | 14.71M |
| December 31, 2021 | 17.36M |
| September 30, 2021 | 28.80M |
| June 30, 2021 | 19.54M |
| March 31, 2021 | 32.45M |
| December 31, 2020 | 37.81M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.995M
Minimum
Dec 2023
37.81M
Maximum
Dec 2020
17.26M
Average
13.18M
Median
Total Liabilities (Quarterly) Benchmarks
| Trxade Health Inc | 11.99M |
| MyMD Pharmaceuticals Inc | 5.493M |
| Acrivon Therapeutics Inc | 12.54M |
| Ligand Pharmaceuticals Inc | 107.35M |
| Regulus Therapeutics Inc | 6.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.08M |
| Shareholders Equity (Quarterly) | -0.622M |